In 2012, our founding team learned cellular reference material, used in a variety of healthcare and diagnostic settings, is sourced and generated from human and animal donors. This seemed crazy to us. To name just a few problems, the existing products were prone to supply chain issues, biological noise, and fundamentally high cost (precluding access to this material for developing nations).
The other half of the reference cell market was spending 30% of their opex making self-generated cell-banks, because no commercially-available products existed to fulfill the need.
As we dug in more to this problem, the challenge was clear: we needed to make a low-cost synthetic cell (biochemically and optically accurate) that retained the benefits of synthetic materials (cheap/scalable production) while mimicking a biological cell:
Our solution is FlowCytes.